PURE Bioscience Company Profile (OTCMKTS:PURE)

About PURE Bioscience (OTCMKTS:PURE)

PURE Bioscience logoPURE Bioscience, Inc. is focused on developing and commercializing antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control. The Company's technology platform is based on stabilized ionic silver and its products contain silver dihydrogen citrate (SDC). It offers PURE Hard Surface as a food contact surface sanitizer and disinfectant to restaurant chains and food processors. It is testing and continuing development of PURE Control to utilize PURE Control as a direct food contact processing aid for raw meats, including beef and pork. In addition to PURE Hard Surface and PURE Control, it manufactures and sells SDC-based products for end use; products preserved with SDC, and SDC as a raw material ingredient for manufacturing use. These products include PURE Multi-Purpose and Floor Cleaner Concentrate, PURE Multi-Purpose Hi-Foam Cleaner Concentrate, Axen 30, Axenohl and SILVERION.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: N/A
  • Sub-Industry: N/A
  • Symbol: OTCMKTS:PURE
  • CUSIP: N/A
  • Web: www.purebio.com
Capitalization:
  • Market Cap: $76.5 million
  • Outstanding Shares: 62,707,000
Average Prices:
  • 50 Day Moving Avg: $1.21
  • 200 Day Moving Avg: $1.00
  • 52 Week Range: $0.75 - $1.36
P/E:
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.000
Sales & Book Value:
  • Annual Revenue: $1.84 million
  • Price / Sales: 41.58
  • Book Value: $0.04 per share
  • Price / Book: 30.50
Profitability:
  • EBIDTA: ($5,720,000.00)
  • Net Margins: -276.96%
  • Return on Equity: -125.22%
  • Return on Assets: -74.90%
Debt:
  • Current Ratio: 1.43%
  • Quick Ratio: 1.29%
Misc:
  • Average Volume: 60,467 shs.
  • Beta: -1.7
  • Short Ratio: 2.56
 
Frequently Asked Questions for PURE Bioscience (OTCMKTS:PURE)

What is PURE Bioscience's stock symbol?

PURE Bioscience trades on the OTCMKTS under the ticker symbol "PURE."

How were PURE Bioscience's earnings last quarter?

PURE Bioscience (OTCMKTS:PURE) announced its quarterly earnings data on Thursday, June, 8th. The company reported ($0.02) earnings per share (EPS) for the quarter, hitting the Thomson Reuters' consensus estimate of ($0.02). The business earned $0.34 million during the quarter, compared to the consensus estimate of $1 million. PURE Bioscience had a negative net margin of 276.96% and a negative return on equity of 125.22%. View PURE Bioscience's Earnings History.

Who are some of PURE Bioscience's key competitors?

Who are PURE Bioscience's key executives?

PURE Bioscience's management team includes the folowing people:

  • David Pfanzelter, Chairman of the Board
  • Henry R. Lambert, Chief Executive Officer, Director
  • Mark Elliott, Chief Financial Officer, Chief Accounting Officer, Vice President - Finance
  • Gary D. Cohee, Director
  • Tom Y. Lee CPA, Independent Director
  • William Otis, Independent Director
  • David M. Theno Jr. Ph.D., Independent Director

How do I buy PURE Bioscience stock?

Shares of PURE Bioscience can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is PURE Bioscience's stock price today?

One share of PURE Bioscience stock can currently be purchased for approximately $1.22.


MarketBeat Community Rating for PURE Bioscience (OTCMKTS PURE)
Community Ranking:  2.5 out of 5 (  )
Outperform Votes:  7 (Vote Outperform)
Underperform Votes:  7 (Vote Underperform)
Total Votes:  14
MarketBeat's community ratings are surveys of what our community members think about PURE Bioscience and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for PURE Bioscience (OTCMKTS:PURE) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for PURE Bioscience (OTCMKTS:PURE)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for PURE Bioscience (OTCMKTS:PURE)
Earnings by Quarter for PURE Bioscience (OTCMKTS:PURE)
Earnings History by Quarter for PURE Bioscience (OTCMKTS PURE)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
6/8/2017Q3 2017($0.02)($0.02)$1.00 million$0.34 millionViewListenView Earnings Details
3/4/2015($0.04)($0.04)$0.20 million$0.27 millionViewN/AView Earnings Details
12/11/2014($0.06)($0.05)$0.30 million$0.12 millionViewN/AView Earnings Details
10/28/2014($0.07)($0.09)$0.36 million$0.13 millionViewN/AView Earnings Details
6/10/2014Q314($0.05)($0.07)$0.26 million$0.26 millionViewN/AView Earnings Details
12/12/2013Q1 14($0.06)($0.19)ViewN/AView Earnings Details
12/12/2012-0.25($0.25)$0.26 million$0.26 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for PURE Bioscience (OTCMKTS:PURE)
Current Year EPS Consensus Estimate: $-0.10 EPS

Dividends

Dividend History for PURE Bioscience (OTCMKTS:PURE)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for PURE Bioscience (OTCMKTS:PURE)
Insider Ownership Percentage: 16.38%
Institutional Ownership Percentage: 0.63%
Insider Trades by Quarter for PURE Bioscience (OTCMKTS:PURE)
Insider Trades by Quarter for PURE Bioscience (OTCMKTS:PURE)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
4/12/2017Henry R. LambertCEOSell3,301$0.95$3,135.95View SEC Filing  
12/21/2016Tom Y. LeeDirectorSell14,885$0.95$14,140.75View SEC Filing  
8/1/2014William OtisDirectorBuy20,000$0.85$17,000.00View SEC Filing  
7/18/2014David M ThenoDirectorBuy30,000$0.85$25,500.00View SEC Filing  
7/2/2014David J PfanzelterDirectorBuy35,294$0.85$29,999.90View SEC Filing  
11/1/2013Henry R LambertCEOBuy40,000$0.75$30,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for PURE Bioscience (OTCMKTS:PURE)
Latest Headlines for PURE Bioscience (OTCMKTS:PURE)
Source:
DateHeadline
finance.yahoo.com logoSeeThruEquity Initiates Coverage on PURE Bioscience (PURE) with a Price Target of $2.45
finance.yahoo.com - July 19 at 5:41 AM
finance.yahoo.com logoRoka Bioscience, Inc. Announces Co-Marketing and Supply Agreement with PURE Bioscience
finance.yahoo.com - July 11 at 6:56 AM
finance.yahoo.com logoPURE Bioscience Announces Co-Marketing and Supply Agreement with Roka Bioscience, Inc.
finance.yahoo.com - July 11 at 6:56 AM
americanbankingnews.com logoPURE Bioscience (PURE) Lifted to "Hold" at ValuEngine
www.americanbankingnews.com - June 20 at 11:40 PM
finance.yahoo.com logoPURE: Update on Fiscal Third Quarter Financials
finance.yahoo.com - June 13 at 7:29 PM
finance.yahoo.com logoEdited Transcript of PURE earnings conference call or presentation 8-Jun-17 8:30pm GMT
finance.yahoo.com - June 10 at 8:40 AM
finance.yahoo.com logoPURE Bioscience, Inc. :PURE-US: Earnings Analysis: Q3, 2017 By the Numbers : June 9, 2017
finance.yahoo.com - June 9 at 7:33 PM
americanbankingnews.com logoPURE Bioscience (PURE) Issues Earnings Results, Hits Expectations
www.americanbankingnews.com - June 9 at 8:26 AM
seekingalpha.com logoPURE Bioscience's (PURE) CEO Hank Lambert on Q3 2017 Results - Earnings Call Transcript
seekingalpha.com - June 9 at 1:16 AM
reuters.com logoBRIEF-Pure Bioscience reports Q3 loss per share of $0.03
www.reuters.com - June 9 at 1:16 AM
finance.yahoo.com logoInvestor Network: Pure Bioscience, Inc. to Host Earnings Call
finance.yahoo.com - June 8 at 8:15 PM
finance.yahoo.com logoPURE Bioscience Reports 2017 Fiscal Third Quarter and Nine-Month Financial Results
finance.yahoo.com - June 8 at 8:15 PM
finance.yahoo.com logoPURE Bioscience to Present at the 2017 Marcum Microcap Conference
finance.yahoo.com - June 1 at 8:38 PM
finance.yahoo.com logoPURE Bioscience Sets Q3 Results Conference Call to Review Progress of SDC-Based Antimicrobial Food Safety Solutions Strategy
finance.yahoo.com - May 30 at 9:41 AM
finance.yahoo.com logoPURE Bioscience Receives Final FDA Acknowledgement Letter
finance.yahoo.com - May 24 at 9:55 AM
seekingalpha.com logoYield10 Bioscience's (YTEN) CEO Oli Peoples on Q1 2017 Results - Earnings Call Transcript
seekingalpha.com - May 12 at 8:08 AM
seekingalpha.com logoCellectar Biosciences' (CLRB) CEO Jim Caruso on Q1 2017 Results - Earnings Call Transcript
seekingalpha.com - May 12 at 12:51 AM
finance.yahoo.com logoPURE Bioscience to Present at the B. Riley & Co. 18th Annual Investor Conference
finance.yahoo.com - May 11 at 7:51 PM
finance.yahoo.com logoPURE Bioscience Receives USDA Permission Letter and FDA FCN Acknowledgement Letter
finance.yahoo.com - April 27 at 10:41 AM
finance.yahoo.com logoPURE Bioscience Receives First Order for PURE Control® Antimicrobial from a Leading Produce Processor
finance.yahoo.com - March 14 at 10:02 AM
finance.yahoo.com logo8:40 am PURE Bioscience receives and ships its first order for PURE Control to a 'leading produce processor'
finance.yahoo.com - March 14 at 10:02 AM
seekingalpha.com logoPURE Bioscience's (PURE) CEO Hank Lambert on Q2 2017 Results - Earnings Call Transcript
seekingalpha.com - March 2 at 7:32 PM
finance.yahoo.com logoPURE Bioscience Reports Improved 2017 Fiscal Second Quarter and Six-Month Financial Results
finance.yahoo.com - March 2 at 7:32 PM
biz.yahoo.com logoPURE BIOSCIENCE, INC. Files SEC form 10-Q, Quarterly Report
biz.yahoo.com - March 2 at 7:32 PM
biz.yahoo.com logoQ2 2017 PURE Biosciences Inc Earnings Release - After Market Close
biz.yahoo.com - March 2 at 8:25 AM
finance.yahoo.com logoPURE Bioscience to Present at the 29th Annual ROTH Capital Partners Conference
finance.yahoo.com - March 1 at 11:55 AM
globenewswire.com logoCoherus BioSciences to Report Fourth Quarter and Full Year 2016 Financial Results on March 13th
globenewswire.com - February 21 at 5:29 PM
finance.yahoo.com logoPURE Bioscience Sets Q2 Results Conference Call to Review Sales and Progress of its SDC-Based Antimicrobial Food Safety Solutions Strategy
finance.yahoo.com - February 9 at 10:14 PM
finance.yahoo.com logoPURE Bioscience Receives FDA Interim Safety Determination Authorization to Test Higher Concentrations of SDC-Based PURE Control® Antimicrobial as a Poultry Processing Aid
finance.yahoo.com - February 6 at 8:57 AM
finance.yahoo.com logoRecent Norovirus Outbreaks in National Media Headlines - Highly Effective PURE® Hard Surface Disinfectant Kills Norovirus in 60 Seconds
finance.yahoo.com - January 28 at 5:51 AM
biz.yahoo.com logoPURE BIOSCIENCE, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote
biz.yahoo.com - January 20 at 9:10 PM
finance.yahoo.com logoPURE Bioscience Well Positioned to Provide Solutions to 2017’s Key Food Safety Challenges
finance.yahoo.com - January 9 at 8:03 PM
zacks.com logoMeridian Bioscience Partners MedCaptain, Expands in China
www.zacks.com - December 21 at 8:36 AM
finance.yahoo.com logoPURE BIOSCIENCE, INC. Financials
finance.yahoo.com - December 20 at 2:02 PM
biz.yahoo.com logoPURE BIOSCIENCE, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exh
us.rd.yahoo.com - December 15 at 9:27 PM
seekingalpha.com logoPURE Bioscience's (PURE) CEO Hank Lambert on Q1 2017 Results - Earnings Call Transcript
seekingalpha.com - December 15 at 6:33 AM
us.rd.yahoo.com logoPURE Bioscience Reports Q1 2017 Financial Results
us.rd.yahoo.com - December 14 at 8:13 PM
biz.yahoo.com logoQ1 2017 PURE Biosciences Inc Earnings Release - After Market Close
biz.yahoo.com - December 14 at 8:22 AM
finance.yahoo.com logoPittsburgh Life Sciences Greenhouse Announces CEO Succession
finance.yahoo.com - December 8 at 7:51 PM
biz.yahoo.com logoPURE BIOSCIENCE, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Sec
biz.yahoo.com - December 7 at 7:17 PM
finance.yahoo.com logoPURE Bioscience Sets Fiscal 2017 Q1 Results Conference Call
finance.yahoo.com - November 30 at 12:22 PM
finance.yahoo.com logoPURE Bioscience to Present at the 9th Annual LD Micro Conference
finance.yahoo.com - November 21 at 12:20 PM
finance.yahoo.com logoPURE Reports Financial Results for Fiscal Year 2016
finance.yahoo.com - October 28 at 6:43 PM
biz.yahoo.com logoQ4 2016 PURE Biosciences Inc Earnings Release - After Market Close
biz.yahoo.com - October 27 at 11:55 AM
finance.yahoo.com logoPURE Bioscience to Host Fiscal 2016 Year-End Financial Results Conference Call
finance.yahoo.com - October 13 at 10:36 AM
seekingalpha.com logoBig pop for disinfectant specialist after inking deal with Chipotle
seekingalpha.com - September 27 at 6:47 PM
finance.yahoo.com logoPURE: Huge Market Opportunity for SDC as a Food Contact Processing Aid
finance.yahoo.com - September 14 at 7:02 PM
finance.yahoo.com logoFour Leading Produce Processors Now Conducting Use Trials with FDA Approved PURE Control® to Prevent Foodborne Illness
finance.yahoo.com - September 12 at 11:34 AM
finance.yahoo.com logoTwo National Restaurant Chains Adopt PURE® Hard Surface Disinfectant as a Food Safety Solution
finance.yahoo.com - September 7 at 10:29 AM
finance.yahoo.com logoPURE Bioscience to Present at Rodman & Renshaw's 2016 Annual Global Investment Conference on September 13th
finance.yahoo.com - August 31 at 12:08 PM

Social

Chart

PURE Bioscience (PURE) Chart for Thursday, July, 27, 2017

This page was last updated on 7/27/2017 by MarketBeat.com Staff